vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $982.9M, roughly 1.4× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.4% vs 7.3%, a 0.1% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (10.8% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $53.3M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 3.9%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
ATR vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $982.9M | $1.3B |
| Net Profit | $72.8M | $97.3M |
| Gross Margin | — | 14.9% |
| Operating Margin | 10.9% | 83.4% |
| Net Margin | 7.4% | 7.3% |
| Revenue YoY | 10.8% | 4.8% |
| Net Profit YoY | -7.5% | -42.0% |
| EPS (diluted) | $1.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $982.9M | $1.3B | ||
| Q4 25 | $962.7M | $339.0M | ||
| Q3 25 | $961.1M | $327.3M | ||
| Q2 25 | $966.0M | $321.4M | ||
| Q1 25 | $887.3M | $330.6M | ||
| Q4 24 | $848.1M | $348.5M | ||
| Q3 24 | $909.3M | $345.5M | ||
| Q2 24 | $910.1M | $336.2M |
| Q1 26 | $72.8M | $97.3M | ||
| Q4 25 | $74.3M | $44.7M | ||
| Q3 25 | $127.9M | $38.7M | ||
| Q2 25 | $111.7M | $34.0M | ||
| Q1 25 | $78.8M | $58.0M | ||
| Q4 24 | $100.9M | $37.5M | ||
| Q3 24 | $100.0M | $33.8M | ||
| Q2 24 | $90.5M | $38.4M |
| Q1 26 | — | 14.9% | ||
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% |
| Q1 26 | 10.9% | 83.4% | ||
| Q4 25 | 11.0% | 19.9% | ||
| Q3 25 | 14.2% | 17.9% | ||
| Q2 25 | 14.9% | 16.8% | ||
| Q1 25 | 12.8% | 21.6% | ||
| Q4 24 | 14.2% | 16.9% | ||
| Q3 24 | 15.2% | 15.0% | ||
| Q2 24 | 13.8% | 11.8% |
| Q1 26 | 7.4% | 7.3% | ||
| Q4 25 | 7.7% | 13.2% | ||
| Q3 25 | 13.3% | 11.8% | ||
| Q2 25 | 11.6% | 10.6% | ||
| Q1 25 | 8.9% | 17.5% | ||
| Q4 24 | 11.9% | 10.8% | ||
| Q3 24 | 11.0% | 9.8% | ||
| Q2 24 | 9.9% | 11.4% |
| Q1 26 | $1.12 | — | ||
| Q4 25 | $1.13 | $0.95 | ||
| Q3 25 | $1.92 | $0.81 | ||
| Q2 25 | $1.67 | $0.70 | ||
| Q1 25 | $1.17 | $1.17 | ||
| Q4 24 | $1.48 | $0.74 | ||
| Q3 24 | $1.48 | $0.66 | ||
| Q2 24 | $1.34 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $229.5M | $245.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $2.6B | $796.3M |
| Total Assets | $5.1B | $2.4B |
| Debt / EquityLower = less leverage | — | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $229.5M | $245.4M | ||
| Q4 25 | $409.5M | $363.4M | ||
| Q3 25 | $264.8M | $296.4M | ||
| Q2 25 | $169.8M | $292.9M | ||
| Q1 25 | $136.8M | $306.8M | ||
| Q4 24 | $226.2M | $320.8M | ||
| Q3 24 | $327.9M | $299.3M | ||
| Q2 24 | $223.9M | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $546.0M | $1.2B | ||
| Q2 25 | $535.1M | $1.2B | ||
| Q1 25 | $561.2M | $1.2B | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — |
| Q1 26 | $2.6B | $796.3M | ||
| Q4 25 | $2.7B | $911.5M | ||
| Q3 25 | $2.8B | $849.2M | ||
| Q2 25 | $2.7B | $882.3M | ||
| Q1 25 | $2.5B | $820.8M | ||
| Q4 24 | $2.5B | $906.9M | ||
| Q3 24 | $2.5B | $878.9M | ||
| Q2 24 | $2.4B | $905.4M |
| Q1 26 | $5.1B | $2.4B | ||
| Q4 25 | $5.3B | $2.5B | ||
| Q3 25 | $5.1B | $2.4B | ||
| Q2 25 | $4.9B | $2.5B | ||
| Q1 25 | $4.5B | $2.5B | ||
| Q4 24 | $4.4B | $2.5B | ||
| Q3 24 | $4.6B | $2.5B | ||
| Q2 24 | $4.5B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | 0.43× | 1.34× | ||
| Q3 25 | 0.20× | 1.44× | ||
| Q2 25 | 0.20× | 1.39× | ||
| Q1 25 | 0.22× | 1.49× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $293.2M |
| Free Cash FlowOCF − Capex | $53.3M | $209.9M |
| FCF MarginFCF / Revenue | 5.4% | 15.7% |
| Capex IntensityCapex / Revenue | 6.7% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $327.0M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $183.7M | $93.6M | ||
| Q3 25 | $177.6M | $111.3M | ||
| Q2 25 | $126.0M | $17.4M | ||
| Q1 25 | $82.7M | $116.6M | ||
| Q4 24 | $178.2M | $43.8M | ||
| Q3 24 | $229.3M | $48.8M | ||
| Q2 24 | $143.6M | $-27.4M |
| Q1 26 | $53.3M | $209.9M | ||
| Q4 25 | $96.9M | $87.2M | ||
| Q3 25 | $114.3M | $106.3M | ||
| Q2 25 | $62.5M | $13.6M | ||
| Q1 25 | $25.9M | $100.9M | ||
| Q4 24 | $112.2M | $35.2M | ||
| Q3 24 | $162.7M | $39.4M | ||
| Q2 24 | $75.4M | $-33.1M |
| Q1 26 | 5.4% | 15.7% | ||
| Q4 25 | 10.1% | 25.7% | ||
| Q3 25 | 11.9% | 32.5% | ||
| Q2 25 | 6.5% | 4.2% | ||
| Q1 25 | 2.9% | 30.5% | ||
| Q4 24 | 13.2% | 10.1% | ||
| Q3 24 | 17.9% | 11.4% | ||
| Q2 24 | 8.3% | -9.8% |
| Q1 26 | 6.7% | 2.5% | ||
| Q4 25 | 9.0% | 1.9% | ||
| Q3 25 | 6.6% | 1.5% | ||
| Q2 25 | 6.6% | 1.2% | ||
| Q1 25 | 6.4% | 4.7% | ||
| Q4 24 | 7.8% | 2.5% | ||
| Q3 24 | 7.3% | 2.7% | ||
| Q2 24 | 7.5% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | 2.47× | 2.09× | ||
| Q3 25 | 1.39× | 2.88× | ||
| Q2 25 | 1.13× | 0.51× | ||
| Q1 25 | 1.05× | 2.01× | ||
| Q4 24 | 1.77× | 1.17× | ||
| Q3 24 | 2.29× | 1.44× | ||
| Q2 24 | 1.59× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
